Alerts will be sent to your verified email
Verify Email
CHANDAN
|
Chandan Healthcare
|
Nephro Care India
|
Invicta Diagnostic
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.17 % | 143.87 % | 36.05 % |
|
5yr average Equity Multiplier
|
2.9 | 18.06 | 1.54 |
|
5yr Average Asset Turnover Ratio
|
1.36 | 1.28 | 1.21 |
|
5yr Avg Net Profit Margin
|
4.66 % | 8.51 % | 20.01 % |
|
Price to Book
|
5.91 | 3.57 | 7.45 |
|
P/E
|
32.64 | 52.58 | 22.19 |
|
5yr Avg Cash Conversion Cycle
|
9.38 Days | -60.13 Days | 3155.19 Days |
|
Inventory Days
|
27.59 Days | 6.87 Days | 7.26 Days |
|
Days Receivable
|
59.72 Days | 13.4 Days | 14.01 Days |
|
Days Payable
|
159.41 Days | 75.6 Days | -2240.05 Days |
|
5yr Average Interest Coverage Ratio
|
5.07 | 32.99 | 40.66 |
|
5yr Avg ROCE
|
20.92 % | 25.8 % | 37.62 % |
|
5yr Avg Operating Profit Margin
|
10.41 % | 13.74 % | 37.67 % |
|
5 yr average Debt to Equity
|
0.68 | 10.46 | 0.32 |
|
5yr CAGR Net Profit
|
n/a | 109.59 % | 82.73 % |
|
5yr Average Return on Assets
|
5.96 % | 12.63 % | 23.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.47 % | 61.47 % | n/a |
|
Share Pledged by Promoters
|
0.0 | 0.0 | n/a |
|
Change in Promoter Holding (3 Yrs)
|
0.04 % | 0.09 % | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | n/a |
|
Chandan Healthcare
|
Nephro Care India
|
Invicta Diagnostic
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|